Skip to content
BioMedsAI
Virtual LabData analysisEnd-to-end packageAvailable now

From sample to paper. We arrange the lab; Padma does the rest.

Send samples and a question. We arrange sequencing and every laboratory experiment with qualified third-party laboratories. Padma takes it from there: quality control, analysis, figures, interpretation and the manuscript, with our scientists beside her. One scope, one invoice, one accountable partner.

Third-party laboratories

  • Single-cell sequencing
  • Bulk and targeted sequencing
  • Proteomics
  • Flow and mass cytometry
  • Spatial profiling
  • Functional experiments

Padma

  • Design review
  • Independent QC
  • Analysis
  • Figures and interpretation
  • The manuscript
  • Delivery

Your samples in. Your paper out.

Six steps, one partner.

  1. 1

    Scope

    A meeting, then a written scope and quote. Padma reviews the design first.

  2. 2

    Samples

    You ship to the partner laboratory we arrange, with documented chain of custody.

  3. 3

    Laboratory

    Sequencing and experiments run by qualified third-party laboratories under their own accreditations.

  4. 4

    QC

    Independent quality control before anyone interprets anything.

  5. 5

    Padma

    Analysis, figures, interpretation and the manuscript, with our scientists beside her.

  6. 6

    Delivery

    The finished study, the paper draft and a sealed, re-runnable bundle, on the platform.

The laboratory side

Arranged with qualified laboratories.

Examples of what we arrange, scoped to your question. Partner laboratories work under their own accreditations; BioMedsAI operates no wet laboratory.

Single-cell sequencing
scRNA-seq, CITE-seq, scATAC and multiome, single-cell DNA
Bulk and targeted sequencing
RNA-seq, WES and WGS, targeted panels, methylation, long-read
Proteomics
Mass spectrometry and affinity-based protein panels
Flow and mass cytometry
Immunophenotyping, sorting before sequencing
Spatial profiling
Spatial transcriptomics and imaging-based assays
Functional experiments
Cell culture, perturbation and drug-response assays, follow-up of candidate targets

Padma's side

Everything else, to the paper.

Padma carries the study from raw data to manuscript, and a BioMedsAI scientist reviews and signs the interpretation.

  1. 1Design reviewExperimental unit, replication, batch and power, checked before a single sample is run.
  2. 2Independent QCData quality judged in writing before any interpretation. We did not generate the data, so we can say when it is not good enough.
  3. 3AnalysisEvery analysis on sealed, versioned engines, with the plan frozen before it runs.
  4. 4Figures and interpretationEvery claim tied to the table that supports it, with its limits stated.
  5. 5The manuscriptMethods, results, figure legends and the data-availability statement, drafted with you.
  6. 6DeliveryA sealed bundle anyone can re-run, plus support for repository submission.

Terms

Project-priced per study and quoted in writing after scoping. Laboratory work is passed through from the partner laboratory. BioMedsAI performs no sequencing itself. Research use only.

A good fit when

  • You have samples and a question, but no core or bioinformatics team.
  • You want one partner accountable from sample to paper.
  • You want the data checked independently before anyone interprets it.
  • You want a study that a reviewer can re-run.

Start with samples and a question.

Thirty minutes with a scientist to scope the study. Nothing is shipped and no data moves before a written, signed scope.